LRP4 and mild neurocognitive disorder: Our observations indicate that abnormalities in postsynaptic n-agrin-LRP4-MuSK signaling could contribute to muscle weakness and disease progression in MND and highlight muscle as an additional target for new therapeutic approaches in MND [6, 28, 29].